Fig. 1From: External validation of urinary C–C motif chemokine ligand 14 (CCL14) for prediction of persistent acute kidney injuryPatient cohort in SAPPHIRE study. Patients with at least one sample that met the persistent severe AKI criteria were considered endpoint positiveBack to article page